文献速递细胞病理与分子病理

基于改良Milan系统的骨与软组织细胞病理学分类再评估

Reappraisal of bone and soft tissue cytopathology classification using the modified Milan system.
PubMed 文献 · Cancer Cytopathol · 2024-07-29

本研究回顾285例骨/关节(173例)和软组织(112例)病变的细胞学病例,采用改良自Milan唾液腺细胞病理学系统的分类进行评分,并与组织学诊断及恶性风险(ROM)比较。所有病例均成功分类,各分类ROM从0%到100%不等;检测恶性的诊断准确率99.4%、灵敏度100%、特异度98.0%。结论认为改良Milan系统及即将推出的WHO系统可能是有用的骨与软组织病变细胞病理学分类工具。

要点

  • 改良Milan系统可将全部骨与软组织细胞学病例分入7个诊断类别。
  • 恶性类别ROM为100%(107/107),非肿瘤和良性肿瘤类别ROM均为0%。
  • 检测恶性的准确率99.4%、灵敏度100%、特异度98.0%。

核心结论

  • 改良Milan系统及WHO系统可能是有用的骨与软组织病变细胞病理学分类工具。

研究设计与样本

  • 回顾性分析285例骨/关节(n=173)和软组织(n=112)病变的细胞学病例。
  • 采用改良自Milan唾液腺细胞病理学系统的分类进行评分,并与组织学诊断比较。

主要发现

  • 285例均成功分类:非诊断性6.3%、非肿瘤性11.9%、意义不明的异型性11.9%、良性肿瘤5.6%、恶性潜能不确定的骨与软组织肿瘤25.3%、可疑恶性1.4%、恶性37.5%。
  • 各分类ROM:非诊断性44.4%(8/18)、非肿瘤性0%(0/34)、意义不明的异型性32.4%(11/34)、良性肿瘤0%(0/16)、恶性潜能不确定的骨与软组织肿瘤16.7%(12/72)、可疑恶性75.0%(3/4)、恶性100%(107/107)。
  • 采用WHO系统时,良性类别(非肿瘤性和良性肿瘤)的比例为17.5%,ROM为0%。
  • 检测恶性的诊断准确率99.4%、灵敏度100%、特异度98.0%。

临床怎么用

  • 在骨与软组织细胞学报告中可尝试采用改良Milan系统进行分类,以标准化诊断并评估恶性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A standardized reporting system for bone and soft tissue tumor cytopathology has not yet been established. The objective of this study was to explore the potential utility of a classification modified from the Milan System for Salivary Gland Cytopathology and compared it with the upcoming World Health Organization (WHO) system for fine-needle aspiration of soft tissue lesions. METHODS: The authors reviewed 285 cytology cases of bone/joint (n = 173) and soft tissue (n = 112) lesions, scoring each within diagnostic categories. The results were compared with histologic diagnoses and the risk of malignancy (ROM) for each category, and diagnostic reliability was analyzed. RESULTS: All 285 cases were successfully classified into one of the following categories: nondiagnostic (6.3%), non-neoplastic (11.9%), atypia of uncertain significance (11.9%), benign neoplasm (5.6%), bone and soft tissue neoplasm of uncertain malignant potential (25.3%), suspicious for malignancy (1.4%), and malignant (37.5%). The ROM was 44.4% (eight of /18 cases) in nondiagnostic, 0% (zero of 34 cases) in non-neoplastic, 32.4% (11 of 34 cases) in atypia of uncertain significance, 0% (zero of 16 cases) in benign neoplasm, 16.7% (12 of 72 cases) in bone and soft tissue neoplasm of uncertain malignant potential, 75.0% (three of four cases) in suspicious for malignancy, and 100% (107 of 107 cases) in malignant categories. Using the WHO system, the proportion and ROM of the benign category (non-neoplastic and benign neoplasm) was 17.5% and 0%, respectively. Among benign and malignant lesions, the diagnostic accuracy, sensitivity, and specificity for detecting malignancy were 99.4%, 100%, and 98.0%, respectively. CONCLUSIONS: The modified Milan system as well as the WHO system may be a useful cytopathologic classification tool for both bone and soft tissue lesions.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Naka M, Yamamoto H, Kohashi K, et al. Reappraisal of bone and soft tissue cytopathology classification using the modified Milan system. Cancer Cytopathol. 2024. PMID: 39074034. doi:10.1002/cncy.22888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。